Ribera-Cortada et al. [23] investigated the terminal B cell differentiation phenotype in 60 MCL, because in vitro work had shown that SOX11, which is commonly expressed in MCL, suppresses a plasma cell differentiation program. Here, SOX11 is linked to mantle cell lymphoma.